アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

orion pharma a/s - cefalexin monohydrate - tablets - 250 milligram

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

orion pharma a/s - cefalexin monohydrate - tablets - 500 milligram

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

orion pharma a/s - cefalexin - granules effervescent - 50 milligram

シンガポール - 英語 - HSA (Health Sciences Authority)

goldplus universal pte ltd - cefalexin monohydrate eqv cefalexin - powder, for suspension - 5300mg/ 100ml - cefalexin monohydrate eqv cefalexin 5300mg/ 100ml

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - cefalotin, quantity: 1 g - injection, powder for - excipient ingredients: sodium bicarbonate - keflin is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. culture and susceptibility studies should be performed. therapy may be instituted before results of susceptibility studies are obtained (see notes under microbiology). respiratory tract infections caused by s. pneumoniae, staphylococci (penicillinase and non-penicillinase-producing), group a beta-haemolytic streptococci, klebsiella, and h. influenzae. skin and soft-tissue infections, including peritonitis, caused by staphylococci (penicillinase and non-penicillinase-producing), group a beta-haemolytic streptococci, e. coli, pr. mirabilis, and klebsiella. genito-urinary tract infections caused by e. coli, pr. mirabilis and klebsiella. septicaemia, including endocarditis, caused by s. pneumoniae, staphylococci (penicillinase and non-penicillinase-producing), group a beta-haemolytic streptococci, s. viridans; e. coli, pr. mirabilis, and klebsiella. bone and joint